Barclays’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-10,758	Closed	-$97K	–	4582
2013 Q4	$97K	Buy	10,758 +4,379	+69%	+$39.5K	﹤0.01%	3049
2013 Q3	$57K	Buy	6,379 +3,166	+99%	+$28.3K	﹤0.01%	3159
2013 Q2	$30K	Buy	+3,213	New	+$30K	﹤0.01%	3558